Marinus Considers Its Options After Mixed Phase III Data

 
• By Joseph Haas
  
Seizures
Marinus is looking to add more seizure indications to ganaxolone's label • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D